Table 1.
Patient # | Age (yrs) at first RFA | Tumor | Site of ablation | # of lesions treated | # lesion treatments (including repeat RFA) | Post RFA -therapy | Overall survival post first RFA (months) |
---|---|---|---|---|---|---|---|
1 | 33 | synovial sarcoma | lung | 1 | 1 | Off protocol RFA Chemotherapy | 21 |
2 | 10 | osteosarcoma | lung | 2 | 2 | Radiotherapy | 8 |
3 | 14 | osteosarcoma | lung | 2 | 3 | none | 48* |
4 | 12 | osteosarcoma | lung | 4 | 4 | Chemotherapy | 12 |
5 | 18 | osteosarcoma | lung | 3 | 3 | Chemotherapy Cryotherapy | 7 |
6 | 16 | osteosarcoma | lung | 1 | 1 | Chemotherapy Surgery | 13 |
7 | 20 | osteosarcoma | lung | 2 | 3 | none | 5 |
8 | 4 | adrenocortical carcinoma | lung | 4 | 16 | Chemotherapy Surgery | 27 |
9 | 19 | hepatocellular carcinoma | liver | 7 | 9 | Chemotherapy Surgery | 60** |
21 | lung | 1 | 1 | ||||
10 | 16 | rhabdomyosarcoma | breast | 1 | 1 | Chemo- | 5 |
11 | 13 | rhabdomyosarcoma | maxilla | 1 | 2 | Chemotherapy | 5 |
12 | 16 | osteosarcoma | lung | 6 | 6 | Chemotherapy Radiotherapy | 12 |
16 | radius | 1 | 1 | ||||
13 | 13 | plantar fibromatosis | feet | 6 | 15 | none | 34** |
14 | 10 | Wilms tumor | lung | 9 | 9 | Chemotherapy | 33** |
15 | 12 | osteosarcoma | lung | 3 | 3 | none | 15 |
16 | 9 | leiomyosarcoma | ribs | 2 | 2 | Antiviral therapy | 26** |
Alive & well at end of study;
Alive with disease at end of study